{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:40:46Z","timestamp":1773898846241,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vaccine.2022.02.024","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T22:28:20Z","timestamp":1645568900000},"page":"2036-2043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3948-9168","authenticated-orcid":false,"given":"Jianqi","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-3803","authenticated-orcid":false,"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2022.02.024_b0005","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1586\/14737175.7.11.1581","article-title":"Postherpetic neuralgia: epidemiology, pathophysiology and management","volume":"7","author":"Johnson","year":"2007","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.024_b0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4065\/84.3.274","article-title":"Herpes zoster (shingles) and postherpetic neuralgia","volume":"84","author":"Sampathkumar","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.vaccine.2022.02.024_b0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/14760584.2018.1495565","article-title":"Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention","volume":"17","author":"Lecrenier","year":"2018","journal-title":"Expert Rev Vaccines."},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.024_b0020","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"MOLECULAR THERAPY."},{"issue":"7-8","key":"10.1016\/j.vaccine.2022.02.024_b0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0734-9750(02)00030-7","article-title":"Production of adenovirus vector for gene therapy","volume":"20","author":"Nadeau","year":"2003","journal-title":"Biotechnol Adv"},{"issue":"10255","key":"10.1016\/j.vaccine.2022.02.024_b0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","article-title":"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia","volume":"396","author":"Logunov","year":"2020","journal-title":"The Lancet."},{"key":"10.1016\/j.vaccine.2022.02.024_b0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bej.2016.02.003","article-title":"Characterization and comparison of ATF and TFF in stirred bioreactors for continuous mammalian cell culture processes","volume":"110","author":"Karst","year":"2016","journal-title":"Biochem Eng J"},{"issue":"47","key":"10.1016\/j.vaccine.2022.02.024_b0040","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1016\/j.vaccine.2019.06.005","article-title":"Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems","volume":"37","author":"Coronel","year":"2019","journal-title":"Vaccine."},{"issue":"10","key":"10.1016\/j.vaccine.2022.02.024_b0045","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1002\/bit.27470","article-title":"Virus harvesting in perfusion culture: Choosing the right type of hollow fiber membrane","volume":"117","author":"Nikolay","year":"2020","journal-title":"Biotechnol Bioeng."},{"key":"10.1016\/j.vaccine.2022.02.024_b0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jbiotec.2017.01.020","article-title":"Shear contributions to cell culture performance and product recovery in ATF and TFF perfusion systems","volume":"246","author":"Wang","year":"2017","journal-title":"J Biotechnol."},{"key":"10.1016\/j.vaccine.2022.02.024_b0055","first-page":"771","article-title":"Understanding pharmaceutical quality by design","volume":"16","author":"Yu","year":"2014","journal-title":"Am Assoc Pharm Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.024_b0060","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1016\/S2214-109X(16)30367-9","article-title":"Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"5","author":"Li","year":"2017","journal-title":"The Lancet Global Health."},{"issue":"2","key":"10.1016\/j.vaccine.2022.02.024_b0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10616-020-00377-9","article-title":"Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach","volume":"72","author":"Nie","year":"2020","journal-title":"Cytotechnology"},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.024_b0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1021\/bp025585a","article-title":"PH, pCO2, and temperature effect on R-adenovirus production","volume":"19","author":"Jardon","year":"2003","journal-title":"Biotechnol Prog."},{"issue":"7","key":"10.1016\/j.vaccine.2022.02.024_b0080","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/bit.20074","article-title":"Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures","volume":"86","author":"Henry","year":"2004","journal-title":"Biotechnol Bioeng."},{"issue":"22","key":"10.1016\/j.vaccine.2022.02.024_b0085","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.vaccine.2017.10.112","article-title":"High-cell-density cultivations to increase MVA virus production","volume":"36","author":"V\u00e1zquez-Ram\u00edrez","year":"2018","journal-title":"Vaccine."},{"issue":"5-6","key":"10.1016\/j.vaccine.2022.02.024_b0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ymben.2005.08.002","article-title":"Metabolic flux analysis of HEK-293 cells in perfusion cultures for the production of adenoviral vectors","volume":"7","author":"Henry","year":"2005","journal-title":"Metab Eng."},{"key":"10.1016\/j.vaccine.2022.02.024_b0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1472-6750-11-84","article-title":"Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture","volume":"11","author":"Petiot","year":"2011","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.vaccine.2022.02.024_b0100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fbioe.2020.00617","article-title":"An Alternative Perfusion Approach for the Intensification of Virus-Like Particle Production in HEK293 Cultures","volume":"8","author":"Lavado-Garcia","year":"2020","journal-title":"Front Bioeng Biotechnol."},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.024_b0105","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/bp034237l","article-title":"High-titer adenovirus vector production in 293S cell perfusion culture","volume":"20","author":"Cortin","year":"2004","journal-title":"Biotechnol Prog."},{"issue":"2","key":"10.1016\/j.vaccine.2022.02.024_b0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/bit.260370205","article-title":"Crossflow microfiltration of animal cells","volume":"37","author":"Maiorella","year":"1991","journal-title":"Biotechnol Bioeng."},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.024_b0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jbiotec.2003.09.012","article-title":"Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity","volume":"107","author":"Maranga","year":"2004","journal-title":"J Biotechnol."},{"issue":"2","key":"10.1016\/j.vaccine.2022.02.024_b0120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/bit.26811","article-title":"The effects of alternating tangential flow (ATF) residence time, hydrodynamic stress, and filtration flux on high-density perfusion cell culture","volume":"116","author":"Walther","year":"2019","journal-title":"Biotechnol Bioeng."},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.024_b0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jbiotec.2011.11.007","article-title":"Optimization of HEK-293S cell cultures for the production of adenoviral vectors in bioreactors using on-line OUR measurements","volume":"157","author":"G\u00e1lvez","year":"2012","journal-title":"J Biotechnol."},{"issue":"2","key":"10.1016\/j.vaccine.2022.02.024_b0130","doi-asserted-by":"crossref","first-page":"1800137","DOI":"10.1002\/biot.201800137","article-title":"Larger Pore Size Hollow Fiber Membranes as a Solution to the Product Retention Issue in Filtration-Based Perfusion Bioreactors","volume":"14","author":"Wang","year":"2019","journal-title":"Biotechnol J."},{"issue":"24","key":"10.1016\/j.vaccine.2022.02.024_b0135","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.vaccine.2014.02.016","article-title":"High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells","volume":"32","author":"Genzel","year":"2014","journal-title":"Vaccine."},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.024_b0140","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/btpr.1704","article-title":"Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor. Part I. Effect of the cell density on the process","volume":"29","author":"Clincke","year":"2013","journal-title":"Biotechnol Prog."},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.024_b0145","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/btpr.2487","article-title":"Alternating flow filtration as an alternative to internal spin filter based perfusion process: Impact on productivity and product quality","volume":"33","author":"Bosco","year":"2017","journal-title":"Biotechnol Prog."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:09:00Z","timestamp":1759403340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0264410X22001591"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}